32-2 Cutaneous Lesions

Current Status
Not Enrolled
Get Started


What a great honor and privilege it is to welcome you...

What a great honor and privilege it is to welcome you once again all to an issue of FAQ that is as timely as it is important. I am secure that with the elite quality of our multidisciplinary reviewers, you will totally enjoy and digest their perspectives on articles that represent these interesting times in the fields of both podiatric medicine and dermatology.

It is highly imperative that the foot and ankle physician be cognizant of the many (sometimes exotic) cutaneous conditions which attack our realm. Thus, it’s important to remember: diagnosis first, and biopsy if needed (even more so with uncommon conditions that mandate a higher index of suspicion – some of which are explored in this issue). These lesions at times necessitate uncommon methods of treatment modalities, and improving one’s skills and diagnostic acumen will certainly lead to increased confidence in managing these difficult but intriguing disorders. Most importantly, it will give our footsore patients better outcomes, as good results and fortunes often favor the well-prepared.

I would like to thank all who contributed to this team personally – each and every one is a true expert, and their efforts, collaboration and dedication to this issue have more than fulfilled my goal of providing relevant clinical pearls to add to each reader’s treatment toolbox. In particular, I’d like to thank my friends and colleagues Drs. Bret Ribotsky and William Scherer for their work on the unique “roundtable” approach to our lecture on Practical Chair-Side Dermatology, as well as our rising star Dr. Ebonie Vincent as she explores in her lecture the rare but fascinating Treeman syndrome. I would also like to offer special thanks to Camryn Vader, an internationally-recognized Grand Challenge Scholar who brings to the mix her unique perspective as an active student in Neuroscience and Public Health.

Those of us who are in the trenches each and every day strive to synthesize the mass of material that comes to us in lectures, journals, websites, email, and even text messages. Hopefully, the insights gained from this issue will facilitate a greater understanding of the cutaneous states, and as such will improve our skills to make the correct diagnoses and select the best treatment options for our patients.

Marc A. Brenner, DPM

© 2021 by Data Trace Publishing Company. All rights reserved. Reproduction or translation of any part of this work beyond that permitted by Section 107 or 108 of the United States Copyright Law without the permission of the copyright owner is unlawful. No portion(s) of the work(s) may be reproduced without written consent from Data Trace Publishing Company. Permission to reproduce copies of articles for non-commercial use may be obtained for a fee of $22 per copy from the Copyright Clearance Center, 222 Rose wood Drive, Danvers, MA 01923, 978-750-8400, www.copyright.com.

The ideas and opinions expressed in Foot and Ankle Quarterly are those of the authors and do not necessarily reflect those of the Editor or the Publisher. Publication of an advertisement or other product mentioned in Foot and Ankle Quarterly should not be construed as an endorsement of the product of the manufacturer’s claims. Readers are encouraged to contact the manufacturer with any questions about the features or limitations of the products mentioned. The Publisher does not assume any responsibility for any injury and/or damage to any persons or property arising out of or related to any use of the material contained in this periodical. The reader is advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each device or of each drug to be administered to verify the dosage, the method and duration of administration, or contraindications. It is the responsibility of the treating physician or other healthcare professionals, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient.



Data Trace Publishing Company Continuing Education Mission Statement

Data Trace Publishing Company is committed to providing high-quality print and internet-based enduring continuing education programs, including lectures, feature articles, and condensations and commentaries on current clinical podiatric topics and medical risk management topics which lead to improved delivery of patient care and help reduce the potential for medical errors. These programs are provided to meet the educational needs of the podiatric medical profession and thereby enhance the quality of patient care.

Program Objectives

Foot and Ankle Quarterly (FAQ) is a unique program designed to help today’s podiatric physician manage an ever-increasing flow of information. After completing the Foot and Ankle Quarterly, Volume 32 program, the learner should be better able to: develop and refine a perspective on current treatment recommendations, updates, and advances pertinent to podiatric practice; evaluate the implications of the learned information as it pertains to the diagnosis and treatment of podiatric disorders and societal issues and barriers, and; apply current trends, standards, and best practices into learner’s own practice.

Data Trace Publishing Company Continuing Education Accreditation Statement

Data Trace Publishing Company is approved by the Council on Podiatric Medical Education (CPME) as a provider of continuing education in podiatric medicine. Data Trace Publishing Company has approved this activity for a maximum of 6 continuing education contact hours (CECHs). Physicians should claim only the contact hours commensurate with the extent of their participation in the activity.

Estimated time to complete activity: 6 hours
Date of release: July 9, 2021
Expiration Date: July 31, 2024 (unless further validated and extended by provider). For amended dates of activity expiration, please see FAQ Activity Effective Dates at www.datatrace.com).

Commercial Interests

No commercial interest provided financial support for this continuing education activity.


Participants of Volume 32, Issue 2 will receive a maximum of 6 CECHs for a correctly-completed CME Answer Form. In order to qualify for CECHs, a score of 70% or more must be achieved on the written examination material. Any participant who does not pass the first time may take the exam one additional time (within 90 days of receipt of results). One retake test may be taken for a fee of $15. You will be responsible for notifying your state of the number of contact hours you have received.

Participants are required to complete a course evaluation for use in developing future issues and to meet the unique educational needs of podiatric physicians.


It is the policy of Data Trace Publishing Company to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All faculty, presenters, speakers, authors, and reviewers participating in any programs provided by Data Trace Publishing Company are expected to disclose any relevant financial relationships with CPME-defined commercial interests to the program audience. “Relevant financial relationships” are financial relationships of the individual (including those of the individual’s spouse or partner) in any amount occurring within the past 12 months that create a conflict of interest. A commercial interest is any organization manufacturing, producing, marketing, re-selling, or distributing healthcare goods or services consumed by or used on patients. The CPME mandates that the content of accredited activities be objective and independent of commercial bias. The intent of this policy is that readers may form their own judgements about the presentations, using independent review to resolve all identified conflicts of interest.

In addition to disclosing commercial relationships, faculty are advised of the following policies:

Each continuing education planner and author has submitted a Conflict of Interest Disclosure in order to identify relevant financial relationships and resolve conflicts.

 Limitations on Data: Presenter will ensure, to the extent possible, meaningful disclosure of limitations on data (e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion).

 Discussion of Unapproved Uses: If unapproved (unlabeled) uses are discussed during the continuing education activity, the presenter will disclose when a product is not approved in the United States (and/or the nation where the activity takes place) for the use under discussion.

Data Trace Publishing Company has identified the option to disclose as follows:

The following authors have disclosed whether they or a member of their immediate family:

  1. Will be receiving an honorarium for this activity
  2. Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author:
    1. Received monetary or other significant research support
    2. Are or had been a paid consultant
    3. Are or had been a full-time or part-time employee
    4. Are or had been a paid or unpaid member of an advisory or similar board
    5. Are or had been a member or on the Board of Trustees
    6. Other
  3. Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author, BUT will not be recommending any of their products over similar competitor products
  4. Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author, AND will be recommending one or more of their products over similar competitor products. Recommendation will be based on:
  1. Exclusively on data and/or clinical experience not generated by the manufacturer or derived from manufacturer-sponsored studies
  2. Data and/or clinical experience most of which were not generated by the manufacturer or derived from manufacturer-sponsored studies
  3. Data and/or clinical experience, most of which were generated by the manufacturer or derived from manufacturer-sponsored studies
  4. Exclusively on data and/or clinical experience generated by the manufacturer or derived from manufacturer or derived from manufacturer-sponsored studies
    n. Have no conflicts to disclose

Article Authors and Lecturers

Marc A. Brenner, DPM (1. Data Trace Publishing Company)
Pradeep Albert, MD (n.)
Elizabeth M. Bonarigo, DPM (n.)
Javier Cavazos, Jr., DPM (n.)
Byron N. Collier, DPM (n.)
Lawrence B. Harkless, DPM (n.)
Annette Joyce, DPM (n.)
Steve McClain, MD (n.)
Michael S. Nirenberg, DPM (n.)
Albert Raminfard, DO (n.)
Kim Rhatigan, MA (n.)
Bret M. Ribotsky, DPM (1. Data Trace Publishing Company)
William P. Scherer, DPM, MS (1. Data Trace Publishing Company; 3. Bako Diagnostics)
Laura Shin, DPM, PhD (n.)
Michael J. Trepal, DPM (n.)
Camryn Vader (n.)
Ebonie Vincent, DPM (n.)

FAQ Journal Planning Committee

Chrissy Calvert (n.)
Kimberly Collignon (n.)
Rachel Miller (n.)
Lauren Molander (n.)
Stephanie Wu, DPM, MSc (n.)

Guest Editor

Marc A. Brenner, DPM

Founder and Chief, Institute of Diabetic Foot Research, Glendale, NY; Medical staff, Northwell Health, Manhasset, NY; Adjunct Clinical Associate Professor, Touro College of Osteopathic Medicine, New York, NY; Visiting lecturer, New York College of Podiatric Medicine, New York, NY; Past Course Director, Podiatric Medicine and Wound Care, South Louisiana Clinical Research Foundation, Houma, LA; Past President and Fellow, American Society of Podiatric Dermatology; Editor-in-Chief, Management of the Diabetic Foot; Private Practice, Old Westbury, NY


Pradeep Albert, MD
Clinical Professor of Radiology, New York College of Osteopathic Medicine, Old Westbury, NY; Professor of Radiology, New York College of Podiatric Medicine, New York, NY; Diplomate, American Board of Radiology

Elizabeth M. Bonarigo, DPM
Attending and Clinical Instructor, Department of Medicine, New York College of Podiatric Medicine, New York, NY; Diplomate, American Board of Podiatric Medicine

Javier Cavazos, Jr., DPM, FACPM, FFPM, RCPS (Glasg.)
Fellow/President-Elect, American College of Podiatric Medicine; Fellow, Royal College of Physicians and Surgeons (Glasg.); RGV Footcare PA, McAllen, TX

Byron N. Collier, DPM
Private practice, Five Cities Foot and Ankle, Pismo Beach, CA; Associate, American College of Foot and Ankle Surgeons

Lawrence B. Harkless, DPM
Interim Dean and Professor of Surgery, University of Texas Rio Grande Valley School of Podiatric Medicine; Founding Dean Emeritus and Professor Emeritus, Western University of Health Sciences College of Podiatric Medicine, Pamona, CA; Fellow, American College of Foot and Ankle Surgeons; Fellow, American College of Podiatric Medicine: Master American Professional Wound Care Association

Annette Joyce, DPM
Director, 360 Care, Louisville, KY; Board of Trustees, Council for Nail Disorders; House of Delegates, South Carolina Podiatric Medical Association; Representative, South Carolina Carrier Advisory Committee Representative, American Podiatric Medical Association; Private practice, Pawleys Island, SC

Steve McClain, MD
Medical Director, McClain Laboratories, Smithtown, NY; Adjunct Professor of Dermatology and Emergency Medicine, SUNY Stony Brook, Stony Brook, NY; Fellow, American Academy of Dermatology; Fellow, Academy of Physicians in Wound Healing; Board certified in Clinical and Dermatopathology

Michael S. Nirenberg, DPM
Clinical and forensic podiatrist, Friendly Foot Care, Crown Point, IN; President, American Society of Forensic Podiatry

Albert Raminfard, DO
Chief Resident of Internal Medicine, Northwell Mather Hospital, Port Jefferson, NJ; Leader, Northwell Eastern Region Resident and Fellow Association

Kim Rhatigan, MA, HTL (ASCP), CPHQ
Technical Director, McClain Laboratories, Smithtown, NY; Certified Professional in Healthcare Quality (CPHQ); HTL, American Society of Clinical Pathology

Bret M. Ribotsky, DPM
Renowned lecturer, entrepreneur, podiatric political leader; Past President, ACFAOM, PM News Lifetime Achievement Award winner, 2016; Podiatry Hall of Fame, Boca Raton, FL

William P. Scherer, DPM, MS
Senior Podiatric Medical Advisor, Bako Diagnostics, Diplomate, American Board of Podiatric Surgery, Private Practice, Boca Raton, FL

Laura Shin, DPM, PhD
Assistant Professor of Clinical Surgery, Keck Medicine of the University of Southern California Department of Vascular Surgery, Los Angeles, CA

Michael J. Trepal, DPM
Professor of Surgery, Vice President for Academic Affairs and Dean, New York College of Podiatric Medicine, New York, NY

Camryn Vader
Student, Tulane University, New Orleans, LA; BS candidate in neuroscience, BSPH candidate in Public Health; Intern, McClain Laboratories, Smithtown, NY; Volunteer, Emergency Department, University Medical Center, New Orleans, LA; Active Member, American Medical Women’s Association

Ebonie Vincent, DPM
Private practice, OC Podiatry, Orange County, CA; Diplomate, American Board of Podiatric Medicine; Member, American Podiatric Medical Association; Member, National Medical Association

In This Issue:

  • FEATURE ARTICLE: In the Hunt for Ectodermal Dysplasia: A Review Article
    Marc A. Brenner, DPM and Albert Raminfard, DO
    • Pernio-Like Skin Lesions Associated with COVID-19: A Case Series of 318 Patients from Eight Countries
      Commentary by Michael S. Nirenberg, DPM
    • Sole-Searing Pain: Classic Kaposi’s Sarcoma
      Commentary by Annette Joyce, DPM
    • A Survey Study with Assessment of Esophageal Screening and Genetic Counseling in Patients with Howel-Evans Syndrome
      Commentary by Elizabeth M. Bonarigo, DPM
    • Proteus Syndrome of the Foot: A Case Report and Literature Review
      Commentary by Lawrence B. Harkless, DPM
    • Trends and Histopathological Patterns of Kaposi’s Sarcoma at the University of Benin Teaching Hospital, Benin City, Nigeria
      Commentary by Camryn Vader, Steve McClain, MD and Kim Rhatigan, MA
    • Treatment of Feet Deformities in Epidermolysis Bullosa
      Commentary by Michael J. Trepal, DPM
    • Hereditary Palmoplantar Keratoderma: A Practical Approach to the Diagnosis
      Commentary by G. Javier Cavazos, Jr., DPM
    • Diagnosis and Management of Acral Lentiginous Melanoma
      Commentary by Laura Shin, DPM, PhD
    • Erosio Interdigitalis Blastomycetica: A Review of Interdigital Candidiasis
      Commentary by Byron N. Collier, DPM
    • Chronic Madura Foot: Mycetoma and/or Actinomyces or Actinomycosis
      Commentary by Michael S. Nirenberg, DPM and Pradeep Albert, MD
  • AUDIO LECTURE 1: Treeman Syndrome
    Ebonie Vincent, DPM
  • AUDIO LECTURE 2: Practical Chair-Side Dermatology: A Roundtable Discussion
    Marc A. Brenner, DPM, Bret M. Ribotsky, DPM and William P. Scherer, DPM, MS